The expression levels of CYP4B1 (lung adenocarcinoma, bladder Urothelial Carcinoma, bladder urothelial carcinoma, and breast invasive carcinoma) showed a significant relationship with different subtypes of these cancers (Figure S12). This evidence concerns the gene CYP4B1 and bladder transitional cell carcinoma.